L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: Public health implications

J. F. Rosen, Morri E. Markowitz, Polly E. Bijur, S. T. Jenks, L. Wielopolski, J. A. Kalef-Ezra, D. N. Slatkin

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Mild to moderate lead toxicity (blood lead, 25-55 μg/dl) is a preventable pediatric illness affecting several million preschool children ('lead-toxic children') in the United States. In-hospital lead-chelation treatment is predicated upon a positive CaNa2EDTA test, which is difficult to perform and impractical in large populations. After the development of an L-line x-ray fluorescence technique (LXRF) that measures cortical bone lead content safely, rapidly, and non-invasively, this study was initiated in lead-toxic children to compare LXRF with the CaNa2EDTA test. Moreover, LXRF provided the opportunity to quantify bone lead content. From blood lead and LXRF alone, 90% of lead-toxic children were correctly classified as being CaNa2EDTA-positive or -negative. In 76% of 59 lead-toxic children, bone lead values measured by LXRF were equal to or greater than those measured in normal and industrially exposed adults. These results indicate that LXRF may be capable of replacing the CaNa2EDTA test. When considered with the known neurotoxic effects on children of 'low levels' of exposure to lead, these results also suggest that either an excessively narrow margin of safety or insufficient safety is provided by present U.S. guidelines, which classify an elevated blood lead concentration as 25 μg/dl or greater.

Original languageEnglish (US)
Pages (from-to)685-689
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume86
Issue number2
StatePublished - 1989

Fingerprint

Poisons
Public Health
Fluorescence
X-Rays
Child Health
Lead
Cortical Bone
Safety
Bone and Bones
Preschool Children
Guidelines
Pediatrics

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children : Public health implications. / Rosen, J. F.; Markowitz, Morri E.; Bijur, Polly E.; Jenks, S. T.; Wielopolski, L.; Kalef-Ezra, J. A.; Slatkin, D. N.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 86, No. 2, 1989, p. 685-689.

Research output: Contribution to journalArticle

@article{e24ba2c2df72453ea62294f7181e4008,
title = "L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: Public health implications",
abstract = "Mild to moderate lead toxicity (blood lead, 25-55 μg/dl) is a preventable pediatric illness affecting several million preschool children ('lead-toxic children') in the United States. In-hospital lead-chelation treatment is predicated upon a positive CaNa2EDTA test, which is difficult to perform and impractical in large populations. After the development of an L-line x-ray fluorescence technique (LXRF) that measures cortical bone lead content safely, rapidly, and non-invasively, this study was initiated in lead-toxic children to compare LXRF with the CaNa2EDTA test. Moreover, LXRF provided the opportunity to quantify bone lead content. From blood lead and LXRF alone, 90{\%} of lead-toxic children were correctly classified as being CaNa2EDTA-positive or -negative. In 76{\%} of 59 lead-toxic children, bone lead values measured by LXRF were equal to or greater than those measured in normal and industrially exposed adults. These results indicate that LXRF may be capable of replacing the CaNa2EDTA test. When considered with the known neurotoxic effects on children of 'low levels' of exposure to lead, these results also suggest that either an excessively narrow margin of safety or insufficient safety is provided by present U.S. guidelines, which classify an elevated blood lead concentration as 25 μg/dl or greater.",
author = "Rosen, {J. F.} and Markowitz, {Morri E.} and Bijur, {Polly E.} and Jenks, {S. T.} and L. Wielopolski and Kalef-Ezra, {J. A.} and Slatkin, {D. N.}",
year = "1989",
language = "English (US)",
volume = "86",
pages = "685--689",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "2",

}

TY - JOUR

T1 - L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children

T2 - Public health implications

AU - Rosen, J. F.

AU - Markowitz, Morri E.

AU - Bijur, Polly E.

AU - Jenks, S. T.

AU - Wielopolski, L.

AU - Kalef-Ezra, J. A.

AU - Slatkin, D. N.

PY - 1989

Y1 - 1989

N2 - Mild to moderate lead toxicity (blood lead, 25-55 μg/dl) is a preventable pediatric illness affecting several million preschool children ('lead-toxic children') in the United States. In-hospital lead-chelation treatment is predicated upon a positive CaNa2EDTA test, which is difficult to perform and impractical in large populations. After the development of an L-line x-ray fluorescence technique (LXRF) that measures cortical bone lead content safely, rapidly, and non-invasively, this study was initiated in lead-toxic children to compare LXRF with the CaNa2EDTA test. Moreover, LXRF provided the opportunity to quantify bone lead content. From blood lead and LXRF alone, 90% of lead-toxic children were correctly classified as being CaNa2EDTA-positive or -negative. In 76% of 59 lead-toxic children, bone lead values measured by LXRF were equal to or greater than those measured in normal and industrially exposed adults. These results indicate that LXRF may be capable of replacing the CaNa2EDTA test. When considered with the known neurotoxic effects on children of 'low levels' of exposure to lead, these results also suggest that either an excessively narrow margin of safety or insufficient safety is provided by present U.S. guidelines, which classify an elevated blood lead concentration as 25 μg/dl or greater.

AB - Mild to moderate lead toxicity (blood lead, 25-55 μg/dl) is a preventable pediatric illness affecting several million preschool children ('lead-toxic children') in the United States. In-hospital lead-chelation treatment is predicated upon a positive CaNa2EDTA test, which is difficult to perform and impractical in large populations. After the development of an L-line x-ray fluorescence technique (LXRF) that measures cortical bone lead content safely, rapidly, and non-invasively, this study was initiated in lead-toxic children to compare LXRF with the CaNa2EDTA test. Moreover, LXRF provided the opportunity to quantify bone lead content. From blood lead and LXRF alone, 90% of lead-toxic children were correctly classified as being CaNa2EDTA-positive or -negative. In 76% of 59 lead-toxic children, bone lead values measured by LXRF were equal to or greater than those measured in normal and industrially exposed adults. These results indicate that LXRF may be capable of replacing the CaNa2EDTA test. When considered with the known neurotoxic effects on children of 'low levels' of exposure to lead, these results also suggest that either an excessively narrow margin of safety or insufficient safety is provided by present U.S. guidelines, which classify an elevated blood lead concentration as 25 μg/dl or greater.

UR - http://www.scopus.com/inward/record.url?scp=0010451953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0010451953&partnerID=8YFLogxK

M3 - Article

C2 - 2492111

AN - SCOPUS:0010451953

VL - 86

SP - 685

EP - 689

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 2

ER -